| 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors RB Perkins, RS Guido, PE Castle, D Chelmow, MH Einstein, F Garcia, ... Journal of lower genital tract disease 24 (2), 102-131, 2020 | 870 | 2020 |
| ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing CC Pritchard, C Smith, SJ Salipante, MK Lee, AM Thornton, AS Nord, ... The Journal of Molecular Diagnostics 14 (4), 357-366, 2012 | 214 | 2012 |
| Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease K Susztak, E Bottinger, A Novetsky, D Liang, Y Zhu, E Ciccone, D Wu, ... Diabetes 53 (3), 784-794, 2004 | 172 | 2004 |
| Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors GS Huang, JS Gebb, MH Einstein, S Shahabi, AP Novetsky, GL Goldberg American journal of obstetrics and gynecology 196 (3), 243. e1-243. e5, 2007 | 164 | 2007 |
| BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma KP Pennington, T Walsh, M Lee, C Pennil, AP Novetsky, KJ Agnew, ... Cancer 119 (2), 332-338, 2013 | 154 | 2013 |
| Monozygotic twinning: an eight-year experience at a large IVF center J Knopman, LC Krey, J Lee, ME Fino, AP Novetsky, N Noyes Fertility and sterility 94 (2), 502-510, 2010 | 129 | 2010 |
| Evidence-based consensus recommendations for colposcopy practice for cervical cancer prevention in the United States N Wentzensen, LS Massad, EJ Mayeaux Jr, MJ Khan, AG Waxman, ... Journal of lower genital tract disease 21 (4), 216-222, 2017 | 116 | 2017 |
| Effect of surgical volume on route of hysterectomy and short-term morbidity LR Boyd, AP Novetsky, JP Curtin Obstetrics & Gynecology 116 (4), 909-915, 2010 | 116 | 2010 |
| BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin T Safra, L Borgato, MO Nicoletto, L Rolnitzky, S Pelles-Avraham, R Geva, ... Molecular cancer therapeutics 10 (10), 2000-2007, 2011 | 108 | 2011 |
| Pilot phase II trial of radiation “sandwiched” between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC) AL Fields, MH Einstein, AP Novetsky, J Gebb, GL Goldberg Gynecologic oncology 108 (1), 201-206, 2008 | 98 | 2008 |
| Trends in bilateral oophorectomy at the time of hysterectomy for benign disease AP Novetsky, LR Boyd, JP Curtin Obstetrics & Gynecology 118 (6), 1280-1286, 2011 | 85 | 2011 |
| A randomized trial of cerclage vs. 17 α-hydroxyprogesterone caproate for treatment of short cervix SM Keeler, D Kiefer, M Rochon, JN Quinones, AP Novetsky, O Rust Walter de Gruyter 37 (5), 473-479, 2009 | 83 | 2009 |
| Frequent mutations in the RPL22 gene and its clinical and functional implications AP Novetsky, I Zighelboim, DM Thompson Jr, MA Powell, DG Mutch, ... Gynecologic oncology 128 (3), 470-474, 2013 | 74 | 2013 |
| A demonstration of automated visual evaluation of cervical images taken with a smartphone camera Z Xue, AP Novetsky, MH Einstein, JZ Marcus, B Befano, P Guo, ... International Journal of Cancer 147 (9), 2416-2423, 2020 | 56 | 2020 |
| Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis JC Wang, A Novetsky, C Chen, AD Novetsky British journal of haematology 119 (3), 709-712, 2002 | 48 | 2002 |
| Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer AP Novetsky, DM Thompson, I Zighelboim, PH Thaker, MA Powell, ... International journal of gynecologic Cancer 23 (2), 2013 | 37 | 2013 |
| Survival and toxicity differences between 5‐day and weekly cisplatin in patients with locally advanced cervical cancer MH Einstein, AP Novetsky, M Garg, SM Hailpern, GS Huang, A Glueck, ... Cancer 109 (1), 48-53, 2007 | 37 | 2007 |
| Preparedness of Ob/Gyn residents for fellowship training in gynecologic oncology DW Doo, M Powell, A Novetsky, J Sheeder, SR Guntupalli Gynecologic Oncology Reports 12, 55-60, 2015 | 36 | 2015 |
| Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer AR Hagemann, AP Novetsky, I Zighelboim, F Gao, LS Massad, PH Thaker, ... Gynecologic oncology 131 (3), 535-540, 2013 | 35 | 2013 |
| Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer AR Hagemann, AP Novetsky, I Zighelboim, F Gao, LS Massad, PH Thaker, ... Gynecologic oncology 131 (3), 535-540, 2013 | 35 | 2013 |
Francisco GarciaPIma CountyPreverjeni e-poštni naslov na pima.gov
